MEDvidi Review: You Pay for the Doctor, Not a Medication Subscription

What Is MEDvidi?

MEDvidi is a telehealth clinic best known for mental health care that has extended into medical weight management. Its model is structurally different from most of this market: you buy a consultation with a physician, and if a medication is appropriate the prescription goes to your own pharmacy. MEDvidi does not sell, bundle or ship the drug.

That produces a very different risk profile. There is no compounded product line, no captive compounding pharmacy, and no subscription to cancel. What you are buying is clinical time — and MEDvidi is unusually transparent about whose time it is, publishing a roster of named physicians with their credentials, training and experience.

The medication list leans toward established, FDA-approved options: semaglutide under its brand names Ozempic, Wegovy and Rybelsus, with insurance coverage assistance flagged specifically for it; Trulicity (dulaglutide); orlistat as prescription Xenical or over-the-counter Alli; and appetite-suppressant options acting on norepinephrine, dopamine and serotonin.

Pricing is fully published and simple: $195 for the introductory consultation, $159 for a follow-up, or $249 for a package combining both — which MEDvidi advertises as saving $105.

Medications Offered & Pricing

The consultation fee is what MEDvidi charges. Medication cost is entirely separate and depends on your insurance and pharmacy — MEDvidi flags insurance coverage assistance specifically for semaglutide. Because these are FDA-approved products moving through the normal supply chain, your drug cost will look like ordinary pharmacy pricing rather than the flat compounded rates elsewhere in this market, which can be far higher without coverage.

Brand-Name or Compounded?

MEDvidi does not appear to offer compounded GLP-1s. The medications named on its weight loss page are FDA-approved products: semaglutide under the Ozempic, Wegovy and Rybelsus brands, dulaglutide as Trulicity, and orlistat as Xenical or Alli.

For patients who want to avoid the compounded market entirely, this is a meaningful structural advantage. Because MEDvidi does not operate or contract with a compounding pharmacy, it has no commercial incentive to steer you toward a particular compounded product — a conflict that exists at nearly every provider selling its own medication.

MEDvidi also carries genuinely non-GLP-1 alternatives. Orlistat works by blocking lipase to reduce dietary fat absorption, and the appetite-suppressant options act on brain neurotransmitters rather than gut hormones. These give a physician real alternatives for patients who cannot tolerate or do not qualify for a GLP-1.

The Consultation Process

Eligibility

• •A medical professional assesses your physical and emotional state before determining whether medication is appropriate — MEDvidi is explicit that a prescription follows only 'if deemed appropriate in your case.'
• •MEDvidi provides a BMI calculator with detailed category explanations spanning underweight through class III obesity.
• •Because MEDvidi's roots are in mental health care, its assessment explicitly considers emotional as well as physical state — relevant given the interaction between weight, mood and eating behaviour.
• •A specific published BMI threshold for prescribing is not disclosed.
• •State-by-state availability is not published on the weight loss treatment page we reviewed.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Not applicable — MEDvidi does not ship medication. You collect prescriptions from your own pharmacy, which also means no cold-chain risk from mail-order transit.

• •Named physicians with published credentials and experience
• •Ongoing monitoring with plan adjustment at follow-ups
• •Insurance coverage assistance for semaglutide
• •Consultation on nutrition, exercise and stress management alongside prescribing
• •Assessment considering emotional as well as physical state
• •Non-GLP-1 medication alternatives available
• •BMI calculator with detailed category guidance

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who MEDvidi May Be Best For

• •Patients with insurance coverage for a brand-name GLP-1 who need a prescribing physician
• •Anyone who wants to avoid the compounded market entirely
• •People who want to know exactly which physician is treating them before booking
• •Patients who may need a non-GLP-1 option such as orlistat or an appetite suppressant
• •Anyone whose weight concerns intersect with mental health, given MEDvidi's background
• •Patients who dislike subscriptions and prefer paying per visit

Limitations

• •The economics only work with insurance. At $195 up front and $159 per follow-up — with medication on top at pharmacy prices — an uninsured patient will spend far more here than at a flat-rate compounded provider, and get less.
• •Consultation costs accumulate. GLP-1 therapy involves months of titration and monitoring, and each check-in is another $159 unless you bundle. Providers like Rixa Health include unlimited provider contact in the medication price.
• •MEDvidi does not manage your medication at all — no shipping, no refill coordination, no supply continuity. That is a fair trade for avoiding compounded risk, but it means more logistics for you.
• •Weight loss is not MEDvidi's core business. The clinician roster is strong and clearly mental-health-weighted, which is an advantage for some patients and a mismatch for others seeking obesity-medicine specialists.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

MEDvidi is worth understanding as a category rather than a competitor. It is not selling you a GLP-1 — it is selling you a physician, and then getting out of the way. There is no compounded product line, no captive pharmacy, no subscription and no commercial reason to push a particular drug. For patients uneasy about the compounded market, that structural cleanliness has real value, and the published physician roster is more transparency than nearly anyone else in this roundup offers.

The medication list reinforces the point. Orlistat and appetite suppressants alongside semaglutide and dulaglutide means a physician here can actually say no to a GLP-1 and still help you — an option that does not exist at a company whose entire revenue comes from shipping semaglutide.

But the price is hard to justify against the alternatives. $195 to start and $159 per follow-up is roughly five times what Doctronic charges for the same fundamental service, and Sesame's visits start at $34. Unless MEDvidi's mental-health-weighted clinical team is specifically what you want — and for some patients, given how tangled weight and mood can be, it genuinely might be — the same consultation-only model is available far cheaper elsewhere. Price it against your insurance position first: if your plan covers a brand GLP-1, the consultation fee may be the smaller number and this becomes reasonable. If you are paying cash for everything, look at Doctronic or a flat-rate compounded provider instead.